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Abstract
Age-related bone loss is associated with changes in bone cellularity with characteristically low levels of osteoblastogenesis.
The mechanisms that explain these changes remain unclear. Although recent in vitro evidence has suggested a new role for
proteins of the nuclear envelope in osteoblastogenesis, the role of these proteins in bone cells differentiation and bone
metabolism in vivo remains unknown. In this study, we used the lamin A/C null (Lmna
2/2) mice to identify the role of lamin
A/C in bone turnover and bone structure in vivo. At three weeks of age, histological and micro computed tomography
measurements of femurs in Lmna
2/2 mice revealed a significant decrease in bone mass and microarchitecture in Lmna
2/2
mice as compared with their wild type littermates. Furthermore, quantification of cell numbers after normalization with
bone surface revealed a significant reduction in osteoblast and osteocyte numbers in Lmna
2/2 mice compared with their
WT littermates. In addition, Lmna
2/2 mice have significantly lower osteoclast number, which show aberrant changes in their
shape and size. Finally, mechanistic analysis demonstrated that absence of lamin A/C is associated with increase expression
of MAN-1 a protein of the nuclear envelope closely regulated by lamin A/C, which also colocalizes with Runx2 thus affecting
its capacity as osteogenic transcription factor. In summary, these data clearly indicate that the presence of lamin A/C is
necessary for normal bone turnover in vivo and that absence of lamin A/C induces low bone turnover osteopenia
resembling the cellular changes of age-related bone loss.
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Introduction
Age-related bone loss starts after the third decade of life as a
consequence of changes in both hormone levels and bone cell
differentiation and function [1]. In contrast to bone loss associated
with estrogen deficiency, which is explained by increasing levels of
osteoclastic activity, the predominant change in age-related bone
loss is a switch in mesenchymal stem cells (MSC) differentiation
from a predominant osteogenic phenotype in young bone into an
adipogenic phenotype in old bone [2], thus affecting bone
formation and bone quality [3]. The mechanisms explaining this
predominant differentiation of MSC into adipocytes in aging bone
remain to be elucidated.
Amongst the potential mechanisms linking osteoporosis and the
cellular aging process, the role of the proteins of the nuclear
envelope in general and lamin A/C in particular is a subject of
increasing interest [4]. Lamins are intermediate filament proteins
present in the nuclear lamina and matrix that are critical
determinants of nuclear architecture and are important regulators
of stem cells differentiation [5,6]. The lamin family in mammals
includes 7 different proteins (A, AD10, C, C2, B1, B2, and B3).
Most adult mammalian somatic cells contain the three major
lamins A, B1 and C. These various forms are grouped into two
classes, A-type (A, AD10, and C) and B-type (B1 and B2). While B-
type lamins are found in all nucleated somatic cells, the expression
of A-type lamins, which result from alternative splicing events of
the lamin A (Lmna) gene, is developmentally regulated [5]. A-type
lamins are absent from all pre-implantation stage embryonic cells
with their synthesis commencing at about day 9 within the visceral
endoderm and trophoblast. Subsequently, A-type lamins appear
asynchronously in various tissues [5]. In bone, recent evidence has
linked the deficiency of processed lamin A/C with the cellular
features of senile osteoporosis in vitro [7,8] and in vivo [9,10],
suggesting that lamin A/C could play an important role in the
pathogenesis of age-related bone loss.
We have recently tested the effect that absence of lamin A/C
may have on the differentiation of MSC into osteoblasts [7]. Using
a silencing RNA (siRNA) approach, we successfully knocked down
lamin A/C in a model of osteoblastogenesis. We found that lamin
A/C inhibition affects osteoblastogenesis while favors adipogenesis
in vitro. Furthermore, in an in vivo model of autosomal dominant
Enery-Dreifuss muscular dystrophy (EDMD2) mouse obtained
due to a missense L530P variant that affects lamin A/C
expression, Mounkes et al. [9] reported that homozygous
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19313L530P/L530P animals developed features of progeria that
included significantly lower bone mineral density (BMD) as
compared with their heterozygous and wild type (WT) counter-
parts. However, the mechanisms of bone loss and the potential
association between lamin A/C deficiency and senile osteoporosis
have not been fully explored in a lamin A/C null animal model.
In the present study, we further assessed the effect of lamin A/C
knockout in vivo on bone microarchitecture, osteoblast differenti-
ation and bone turnover using lamin A/C (Lmna
2/2) mice. This
model was developed by deleting exons 8–11 of the Lmna gene,
which disrupts both isoforms (A and C), shows a dystrophic
condition related to EDMD2, including the appearance of skeletal
and cardiac muscle alterations and perturbations of the nuclear
envelope [11]. At birth, Lmna
2/2 mice are identical to their hete-
rozygous and WT controls. After birth, homozygous (Lmna
2/2)
mice show accelerated features of aging and have a shorter life
span (,6 weeks) than their heterozygous counterparts. The most
common cause of death in Lmna
2/2 mice is cardiovascular
complications due to atherosclerosis and coronary artery disease
[12].
Our results demonstrate that Lmna
2/2 mice are severely
osteopenic and show low levels of bone turnover associated with
a decrease in bone formation that exceeds the decrease in bone
resorption, clearly mimicking the cellular changes of senile
osteoporosis. In addition, a mechanism explaining the decline in
osteoblastogenesis in Lmna
2/2 mice is proposed. Taken together,
these data confirms previous in vitro data on the role of lamin A/C
in osteoblastic differentiation of MSC differentiation and opens the
path for the development of anabolic drugs that maintain the bone
mass through the regulation of lamin A/C expression and its
interaction with other nuclear proteins in differentiating MSC.
Results
Absence of Lamin A/C Affects Bone Mass and
Microarchitecture
Using Lmna
2/2 mice [11], we analyzed whether absence of
lamin A/C has an effect on bone mass and microarchitecture.
Figure 1 shows a qualitative (A, B) and quantitative (C) decline in
bone density and architecture in Lmna
2/2 mice as compared with
wild type (WT) controls. Whole body analysis of Lmna
2/2 mice
and WT littermate controls (Figure 1A, left panels) shows
dramatically lower bone mass in the mutants as compared WT
controls. In addition, the skull of the mutants show the typical
defects previously reported by Mounkes et al [9]. No significant
difference in either long bone size or diameter was found between
Lmna
2/2 mice as compared with wild type (WT) controls (data not
shown). 3D reconstruction and 2D saggital histological sections of
the distal femur (Figure 1A) showed a significant loss in trabecular
and cortical bone in Lmna
2/2 mice as compared with the WT
controls. Histological and micro-computed tomography (CT)
measurements of distal femur in Lmna
2/2 mice revealed a
significant decrease in bone volume/trabecular volume (BV/
TV), trabecular number (Tb.N), and cortical thickness (Ct.Th)
with a significant increase in trabecular separation (Tb.Sp)
(Figure 1C), compared with their WT littermates (P,0.001).
Furthermore, levels of mineral apposition identified by fluoro-
chrome labelling on two separate dates (day 5 and 2 pre-sacrifice),
showed mineralized surface per bone surface (MS/BS) (WT,
12%; Lmna
2/2, 2%, P,0.001) and mineral apposition rate
(MAR) decreased 4-fold, and the rate of bone formation rate
per bone surface BFR/BS decreased by approximately 10-fold
(WT, 0.5 mm
3/mm
2?d; Lmna
2/2, 0.05 mm
3/mm
2/d, P,0.001)
(Figure 1D). Taken together these data indicate that absence of
lamin A/C in vivo is associated with severe osteopenia, poor bone
microarchitecture and significantly lower levels of bone apposition.
Analysis of Osteoblast Differentiation and Activity
To determine whether the structural changes in bone and the
low bone formation rate observed in Lmna
2/2 mice are associated
with a deficit in bone forming osteoblasts, analysis of osteoblastic
differentiation of pluripotent bone marrow cells and osteoblast
number and activity in bone tissue were performed. After three
weeks in osteogenic media, the number of osteoblast precursors
obtained from bone marrow and represented by colony forming
units – osteoblasts (CFU-OB) was significantly lower in Lmna
2/2
mice as compared with their WT controls (Figure 2A and B,
P,0.001). Furthermore, quantification of cell numbers after
normalization with bone surface revealed a significant reduction
in osteoblast and osteocyte numbers (Figure 2C and D) in
Lmna
2/2 mice compared with their WT littermates (P,0.001).
Furthermore, in agreement with the differences in osteoblast
number, serum levels of procollagen type 1 amino terminal
propeptide (P1NP) (Figure 2D) were significantly lower in Lmna
2/
2 mice compared with their WT littermates (P,0.001).
Finally, we determined whether the reduction in osteoblast
differentiation was associated with changes in the expression of
markers of osteoblast differentiation at the mRNA level (Figure 2E).
We found a significant reduction in the expression levels of mRNA
for osteocalcin (OCN) and osteopontin (OPN) in Lmna
2/2 mice as
compared with their WT controls (P,0.001). In contrast, there
were no differences in mRNA levels of runt-related transcription
factor 2 (Runx2), a critical factor for osteoblastogenesis and an
upstream regulator of OCN and OPN transcription [13].
Analysis of Osteoclast Number and Activity
To determine whether, as in the osteoblast lineage, osteoclasts
are affected by absence of lamin A/C, we stained decalcified
sections of tibiae with tartrate resistant acid phosphatase (TRAP)
to identify osteoclasts (Figure 3A). Quantification of cell numbers
after normalization with bone surface (Figure 3B) revealed a
significant reduction in osteoclast number in Lmna
2/2 mice
compared with their WT littermates (P,0.001). The decrease in
osteoclast number observed in Lmna
2/2 mice (,20%) was
significantly lower than the decrease induced by absence of lamin
A/C on osteoblast number (,47%, P,0.001) (Figure 2C). In
addition, osteoclasts in the Lmna
2/2 mice showed phenotypic
abnormalities including big size and vacuolization (Figure 3A).
Finally, to determine whether the reduction in cell numbers
seen in Lmna
2/2 mice correlated with circulating levels of
biomarkers of osteoclastic activity (bone resorption) similar to
those used in the clinical setting, we measured serum levels of C-
telopeptide (C-Tx) in both null and WT animals. Figure 3B shows
a significant decrease in serum C-Tx in Lmna
2/2 mice as
compared with their WT controls (P,0.01), also correlating with
the lower levels of osteoclast numbers found in the histochemical
analysis.
Circulating Concentrations of Calciotropic Hormones in
Lmna
2/2 mice
To determine whether the changes in bone cellularity and
microarchitecture were due to alterations in serum concentrations
of calciotropic hormones, we measured serum levels of parathyroid
hormone (PTH) and 25-dihydroxy-vitamin D [25(OH)D] in
Lmna
2/2 mice and compared them with their WT controls. As
shown in table 1, there were no differences in serum levels of either
PTH or 25(OH)D between Lmna
2/2 mice and WT controls.
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Interaction in Bone Cells of Lmna
2/2 Mice
Initially, the expression of lamin A protein in bone marrow cells
was determined by western blot (Figure 4 A and B). As expected,
expression of lamin A protein was abolished in the Lmna
2/2 mice
as compared with their WT littermates (Figure 4A). Subsequently,
using nuclear extracts obtained from non-hematopoietic, adherent
stromal cells we assessed the levels of Runx2 protein expression
(Figure 4B). We found that, as in our in vitro [7] and PCR data,
levels of expression of Runx2 protein are not affected by absence
of lamin A/C.
Our next step was to determine whether, as reported in our in
vitro analysis [7], lamin A/C is required for the successful nuclear
binding and thus the transcriptional activity of Runx2. Under
osteogenic conditions, phosphorylated nuclear Runx2 interacts
with a group of proteins known as Smads. The complex Runx2/
Smad factors will then bind to the DNA to activate the
transcription of some of the most important osteogenic factors
such as osteocalcin (OCN) and osteopontin (OPN). To character-
ize whether Runx2 nuclear binding activity was affected by
absence of lamin A/C we used ELISA analysis of Runx2 complex
binding. Our analysis showed a significant reduction in Runx2
DNA binding activity in Lmna
2/2 mice as compared with WT
controls (P,0.001; Figure 4C).
Since alterations in Runx2 complex binding capacity is a
recurrent finding in absence of lamin A/C both in vitro [7] and in
vivo, we therefore hypothesize that this finding could be explained
by changes in the interaction between proteins of the nuclear
envelope, which have been previously associated with alterations
in cell differentiation in other cell models [14]. To assess this
hypothesis, we selected the integral inner nuclear membrane
MAN-1. This protein physically interacts with lamin A/C, which
also acts as a regulator of MAN-1 interaction with other nuclear
proteins [15]. In addition, MAN-1 plays an important inhibitory
role to the interaction between Smads and other intranuclear
proteins [16,17]. Initially we assessed the changes in MAN-1
protein expression in bone marrow cells of Lmna
2/2 and WT
mice. Expression levels of MAN-1 were significantly higher in
nuclear extracts obtained from marrow cells of Lmna
2/2 mice as
compared with WT controls (Figure 4B, P,0.01). We then
assessed the changes in nuclear interaction between Runx2 and
MAN-1 in the absence of lamin A/C by using ex vivo cultures of
Figure 1. Changes in bone architecture in Lmna
2/2 mice. (A) Micro-CT analysis of total body (left panels) and femur of 4-week-old Lmna
2/2
mice and WT littermates. Images representative of two-and three- dimensional reconstructions, obtained with a 0.9u rotation between frames on a
SkyscanH 1072 instrument, are shown for WT mice (A, upper panel) and Lmna
2/2 (A, lower panel) mice. Whole-body CT analysis of Lmna
2/2 mice and
WT littermate controls shows dramatically lower bone accumulation in Lmna
2/2 mice with remarkable skull defects observed in the mutant mice. The
right upper panels are representative of longitudinal sections. The lower right panels show the metaphysis (area just below the growth plate) (M) and
distal diaphysis (cortical structure) (D). Lmna
2/2 mice exhibited profound thinning of cortical bone, a reduction in platelike structures and a lack of
trabecular connectivity. These changes correlated with von Kossa staining (B). Quantitation of bone parameters (C) further exemplified a decrease in
bone volume vs. total volume (BV/TV), trabecular number (Tb.N), and cortical thickness (Ct.Th) with a concomitant increase in trabecular separation
(Tb.Sp) in the mutant femora compared with the WT littermate controls. Results are expressed as the mean 6 SD of eight independent analyses per
group. *P,0.001, significantly different from null mice. (D) Tetracycline-labeled section of the distal femur. The distance between two layers of
tetracycline labels (arrows) visualized by epifluorescence represents bone formation that occurred during the 5-d period between tetracycline
injections. Mutant mice showed a significant decrease in all parameters of bone formation including mineralized surface/bone surface (MS/BS),
mineral apposition rate (MAR) and bone formation rate/bone surface (BFR/BS) as compared with their WT littermates (*P,0.001). Photomicrographs
were obtained on the Bioquant analysis system using a 640 objective.
doi:10.1371/journal.pone.0019313.g001
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Figure 4D, MSC obtained from Lmna
2/2 mice showed smaller
nuclei and lower levels of nuclear MAN-1/Runx2 colocalization
as compared with their WT controls.
Discussion
The present study demonstrates that lamin A/C is required in
osteoblastogenesis and bone formation in vivo. Additionally, mice
lacking lamin A/C showed a decrease in bone formation that
exceeds a decrease in bone resorption resulting in significant bone
loss mimicking the cellular changes observed in senile osteoporosis
[18]. In addition, absence of lamin A/C is associated with 1)
alterations in the nuclear transcription required for osteoblasto-
genesis and; 2) abnormal interaction between Runx2 and MAN-1,
a protein of the nuclear envelope that is closely regulated by lamin
A/C through a direct physical interaction [14].
The importance of proteins of the nuclear envelope in bone
biology has been reinforced by changes in bone mass seen in
patients suffering of mutations that either decrease or increase
Figure 2. Changes in osteoblast differentiation and function of 4 week-old Lmna
2/2 mice. (A and B) Formation of colony forming units-
osteoblasts (CFU-OB) in ex-vivo cultures of bone marrow cells from 3-week-old Lmna
2/2 mice (lower panels) and WT controls (upper panels). The
number of colony forming units-osteoblast (CFU-OB) per femur was significantly higher after 3 wks of differentiation in WT mice compared to
Lmna
2/2 mice (B). (C) Sections of plastic embedded proximal tibiae (secondary spongiosa) from Lmna
2/2 mice and WT controls (n=10 per group)
were stained sequentially with toluidine blue (upper panels, Magnification 640) for osteoblasts (black arrows) and osteocytes (red arrows) and ALP
(lower panels, Magnification620) for osteoblasts (arrows). (D) A significant decrease (247%) in the number of ALP expressing osteoblasts (N.Ob) and
a significant decrease in osteocyte number (N.Ot) (250%) were seen in Lmna
2/2 mice compared with WT
+/+ mice. Micrographs are representative of
those from eight different mice of each genotype. *P,0.001. Changes in osteoblast differentiation and function correlated with changes in a serum
biochemical marker of bone formation (P1NP) in Lmna
2/2 mice compared with WT
+/+ mice. *P,0.001. (E) The reduction in osteoblast differentiation
in Lmna
2/2 mice was associated with lower expression of osteocalcin (OCN) and osteopontin (OPN) at the mRNA level. There were no differences in
Runx2 expression between Lmna
2/2 mice and their WT controls. For PCR, data analysis is expressed as the ratio of the gene of interest vs. GAPDH as
control. Data represent the mean6SD of triplicate determinations. *P,0.001.
doi:10.1371/journal.pone.0019313.g002
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Gilford Progeria Syndrome (HGPS) has been associated with
mutations in the lamin A/C gene [19]. Patients suffering from
HGPS show major bone changes including severe osteoporosis,
osteolysis, bone deformities and spontaneous fractures [20]. In
contrast, mutations in MAN-1 result in three autosomal dominant
diseases in humans known as melorheostosis; all three character-
ized by increased endochondral and intramembranous bone
formation and abnormally high BMD [16].
In the particular case of lamin A/C there is enough evidence to
suggest that this protein plays an important role in bone
metabolism. Considering that in normal physiological conditions
lamin A/C has been associated with telomerase maintenance [21]
and stem cell homeostasis [22], the aging process in tissues that
depend on normal MSC differentiation could be also associated
with changes in lamin A/C expression. This could be the case of
bone, where normal osteoblasts show a decrease in lamin A
expression with aging [23].
Furthermore, the link between lamin A/C and age-related bone
loss is most likely based on the role played by lamin A/C in the
differentiation of MSC. It has been proposed that nuclear proteins,
such as lamin A/C, may act as signalling receptors in the nucleus
required for receiving and/or transducing upstream cytosolic
signals in a number of pathways central to adult stem cell
maintenance [22]. Indeed, alterations in either lamin A/C
processing or expression have been associated with abnormal
differentiation of MSC, which may explain the defects in bone
(osteopenia) [20] and muscle (dystrophy) [11] observed in patients
suffering from severe laminopathies. In terms of processing, lamin
A is the end product of prelamin A after exposed to protein
cleavage and prenylation [5]. Accumulation of unprenylated
prelamin A negatively regulates adipogenic [24] and osteogenic
[25] differentiation of MSC in vitro. Furthermore, mice lacking the
enzyme responsible for lamin A/C processing (Zmpste24
2/2)
show accelerated bone loss and the typical features of senile
osteoporosis [10].
For the purposes of the present study, we assessed the changes in
bone metabolism and microarchitecture in the lamin A/C null
(Lmna
2/2) mice. Low levels of lamin A/C have been associated
with low BMD measured by densitometry in mice [9].
Interestingly, in their mouse model heterozygous mice showed
no difference in BMD as compared with WT animals. For this
reason, we focused our bone phenotype assessment to Lmna
2/2
mice and their WT controls.
Initially, we performed both microCT and histological analysis
of bones of Lmna
2/2 mice at the age of 3 to 4 weeks while the
animals were still in good health and mobility. This time point was
selected due to the short life span of the homozygous mice and to
prevent any impact of comorbidities or limited mobility on bone
metabolism. Microarchitectural analysis demonstrated that bone
mass is significantly lower in the Lmna
2/2 mice compared to WT
control mice, leading to an osteopenic phenotype. This bone loss is
reflected by a significant decrease in trabecular number with a
concomitant increase in trabecular separation as well as a much
lower cortical thickness in Lmna
2/2 mice, a key feature in age-
related bone loss [26]. Furthermore, to analyze the cellular
mechanisms of bone loss in this model, we assessed the changes in
bone cellularity in Lmna
2/2 mice as compared to their WT
littermates. We found that the number of osteoblasts and
osteoclasts relative to the bone volume was significantly reduced
in Lmna
2/2 mice as compared with the WT controls. This
reduction in cell number corresponded with lower concentrations
of serum markers of osteoblastic (P1NP) and osteoclastic (C-
telopeptide) activities. In addition, these changes in bone cellularity
were not associated with changes in serum levels of calciotropic
hormones. In agreement with other reported models of senile
osteoporosis [27,28], in Lmna
2/2 mice the reduction in bone
formation significantly exceeded the decrease in bone resorption
thus becoming a new proposed model of reduced turnover and
senile osteoporosis.
The lower number of osteoclasts found in our in vivo model are
in disagreement with a previous report from Rauner et al [8] in
which absence of lamin A/C in vitro was associated with high levels
Figure 3. Changes in osteoclast number and function of 4
week-old Lmna
2/2 mice. (A) Sections of plastic embedded proximal
tibiae from Lmna
2/2 mice and WT (n=10 per group) were stained
sequentially for TRAP (osteoclasts, OC) (arrows, Magnification 640). A
significant decrease in the number of OC (N.Oc) showing TRAP enzyme
activity (B) was seen in Lmna
2/2 mice compared with WT controls. In
addition, osteoclasts in the Lmna
2/2 mice showed an aberrant
phenotype including giant size and vacuolization (arrows). Micrographs
are representative of those from eight different mice of each genotype.
*p,0.001. (B) Changes in bone cellularity correlated with changes in
serum biochemical markers of bone resorption (CTx: C-telopeptides) in
Lmna
2/2 mice compared with WT controls. *P,0.01.
doi:10.1371/journal.pone.0019313.g003
Table 1. Circulating concentrations of calciotropic hormones
parathyroid hormone (PTH) and 25(OH)-vitamin D [25(OH)D]
in Lmna
2/2 mice vs. WT controls.
Assay WT Lmna
2/2 P value
N=10 N=10
25(OH)D (nmol/l) 48614 60615 NS
PTH (pg/ml) 26662 9 65N S
doi:10.1371/journal.pone.0019313.t001
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come from their in vitro model where combined osteoblasts and
osteoclasts are grown in a well-regulated environment whereas in
the in vivo model the number of variables involved in the
osteoblast-osteoclast interaction is substantial. Indeed, the decrease
in osteoclast number and activity observed in Lmna
2/2 mice could
be due to either lower number of osteoblast precursors, which are
the major source of RANK-L in bone, or to the aberrant osteoclast
phenotype observed in Lmna
2/2 mice. Nevertheless, the role of
lamin A/C in osteoclast differentiation should be the subject of
future studies.
Furthermore, considering that osteocytes are the most abundant
cell in bone, act as mechanosensors and constitute the final fate of
a proportion of osteoblasts [29] and that a recent study associated
lamin A/C with mechanosensing and matrix formation [30], we
looked at the effect that lack of lamin A/C activity may have on
osteocytes number in this model. We found a significant reduction
in trabecular osteocyte number in Lmna
2/2 mice as compared to
their WT controls. More studies looking at the role of proteins of
the nuclear lamina in osteocyte function and mechanotransduc-
tion are required.
As in our in vitro experiments [7] the significant reduction in
osteoblast number in Lmna
2/2 mice was associated with lower
levels of MSC differentiation into osteoblasts in absence of lamin
A/C. In agreement with this evidence, in the present study
non-hematopoietic adherent marrow precursors obtained from
Lmna
2/2 mice showed significantly lower capacity to differentiate
into osteoblasts under osteogenic conditions. Overall, from the
point of view of osteoblast differentiation and activity, this model
of total absence of lamin A/C showed major similarities with a
model of prelamin A accumulation [10] in terms of changes in
osteoblast number and ex vivo differentiation of bone marrow
Figure 4. Mechanism of bone loss in Lmna
2/2 mice. (A and B) Expression of lamin A is abolished in Lmna
2/2 mice as compared with their WT
controls. (*P,0.001) (A). Furthermore, no difference in protein levels of Runx2 were identified in protein extracts from Lmna
2/2 mice vs. WT control
(B). Finally, expression levels of MAN-1 were significantly higher in Lmna
2/2 mice as compared with their WT counterpart (B). Protein levels relative to
tubulin were quantified by densitometry. Data represent the mean6SD of triplicate determinations. *P,0.001. (C) Bone marrow cells obtained from
Lmna
2/2 mice showed a significant reduction in Runx2 DNA binding activity as compared with WT controls (*P,0.01). The data are representative of
three different experiments. (D) Confocal microscopy of nuclei of marrow precursors (passage 2) obtained from tibiae of Lmna
2/2 and WT controls
and cultured ex vivo in MSC growth media for 3 days. In cells obtained from WT mice, Runx2 (green) is widely distributed in the nucleus (upper
panels, white arrows) whereas MAN-1 (red) distribution is mostly limited to the nuclear envelope. In contrast, in absence of lamin A/C (lower panels),
both Runx2 and MAN1 share the same nuclear peripheral colocalization with extremely low levels of Runx2 expression (green) seen in the interior of
the nuclei. Note also the smaller nuclei in MSC obtained from the mutants. DAPI (blue) was used as counterstaining only at lower magnification (left
panels). In right panels, Arrows denote size of colocalization (right panels). Images are representative of cell cultures from 6 different mice.
doi:10.1371/journal.pone.0019313.g004
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differentiation in both models are mostly associated with low levels
of lamin A/C independently of the accumulation of prelamin A
observed in the Zmpste24
2/2 mice. Further studies testing this
hypothesis are still required.
Considering that Runx2 is the most important regulator of
OCN and OPN transcription [31] and that lamin A/C
knockdown affects the nuclear binding capacity of the Runx2
complex in vitro [7], we then attempted to identify whether
osteoblast differentiation is affected by the same mechanism in vivo.
To test this hypothesis, we first looked at levels of Runx2
expression and transcription in Lmna
2/2 mice and WT controls.
We found that expression and transcription of Runx2 in non-
hematopoietic adherent stromal cells is not affected by the absence
of lamin A/C, suggesting that, as in vitro, a similar mechanism
involving the deficient nuclear binding of the Runx2 complex
could constitute the underlying mechanism.
Lamin A/C is in close interaction with multiple nuclear proteins
of the nuclear envelope that act as regulators of cell growth and
differentiation. Although the bone defects observed in severe
laminopathies such as HGPS could be also associated with
accumulation of prelamin A in the presence of normal lamin C
expression [19], for the purposes of this study we tested the role of
the inner nuclear protein MAN-1 as one of the potential
explanations for the limited capacity of the Runx2 complex to
bind the nucleus and initiate osteogenic transcription in the
absence of lamin A/C. The reasons for the selection of MAN-1 as
our target protein have been explained above. The most important
reason is the reported association between mutations in MAN-1
and hyperostosis syndromes, which may be explained by higher
availability of Smads and Runx2 within the nucleus in the absence
of MAN-1 thus facilitating their interaction and increasing bone
formation [16]. In this case, we hypothesized that in the absence of
lamin A/C, which physically interacts and regulates MAN-1
activity in the nucleus [15], Runx2 changes its localization and
availability therefore affecting its capacity to interact and to form
the Runx2 nuclear binding complex, decreasing OCN and OPN
transcription and thus affecting osteoblastogenesis.
To test this hypothesis, we initially assessed the changes in
MAN-1 expression in nuclear extracts obtained from Lmna
2/2
mice and WT controls. Bone marrow cells from Lmna
2/2 mice
showed higher levels of MAN-1 protein expression. These high
levels of MAN-1 expression could be explained by either
potentially enhanced transcription or increased protein stability
of MAN-1 induced by absence of lamin A/C. Overall, additionally
to the already known physical interaction between lamin A/C and
MAN-1 [15], our data suggest a new role of lamin A/C in the
regulation of MAN-1 protein expression that should be explored in
future studies.
Subsequently, we tested nuclear binding capacity of the Runx2
complex. As our in vitro experiments [7], Runx2 DNA binding
activity was significantly reduced in absence of lamin A/C. This
reduced binding activity could also be associated with either high
levelsofMAN-1expressionorbyhigherlevelsoffreeMAN-1,which
could happen after losing its physical interaction with lamin A/C
[15]. As in other models [32,33], high levels of MAN-1 will inhibit
the formation and translocation of osteogenic transcription com-
plexes that interact with Runx2 in the nucleus. We then focused on
the potential interaction between high levels of MAN-1 and Runx2
in the nucleus. Using colocalization we documented that, in absence
of lamin A/C, Runx2 and MAN-1 share a similar localization in the
nucleus of marrow precursors obtained from Lmna
2/2 mice.
In summary, we have demonstrated that lamin A/C is required
for normal bone turnover and bone metabolism. Mice lacking
lamin A/C show the typical features of senile osteoporosis.
Although this bone phenotype could be a direct consequence of
the mutation, other alterations (cardiovascular, neuromuscular, fat
and hematopoiesis) may also be involved and deserve further
exploration. Nevertheless and taken together with previous in vitro
and in vivo studies, this evidence allows us to postulate that a
decrease in lamin A/C could be a determinant player in the
pathogenesis of age-related bone loss.
In conclusion, considering that levels of lamin A expression in
bone progressively decrease with aging [23], it is tempting to
propose that age-related changes in both the levels of lamin A/C
expression by MSC and in the interaction between proteins of the
nuclear lamina are associated with the key features of senile
osteoporosis and could offer a new potential target to prevent bone
loss thus maintaining appropriate levels of bone formation and
bone mass.
Materials and Methods
Ethics statement
All steps were taken to ameliorate suffering in all work involving
our study animals. The institutional Animal Ethics Committee at
the Victor Chang Cardiac Research Institute (Ref. No. #07/11)
approved all protocols, including those referring to analgesia and
manipulation of animals.
Animals
Lmna knockout mice in a C57Bl6x129Sv genetic background
were generated as described [11]. Mice were genotyped by PCR
amplification of tail DNA. Mutant male mice (
2/2) and WT male
littermates (n=10 per group). To measure bone formation rates,
mice were injected ip with 30 mg/g body weight of tetracycline 7
and 2 d before they were killed. Mice were sacrificed at 4 weeks of
age. Both side tibiae and femora were obtained for further
analysis. All experiments and measurements were repeated at least
three times.
Quantitative Radiologic Imaging
Micro-CT was performed in total body and femur of Lmna
2/2
mice and WT controls as previously described [10]. For femur
analysis, after removal of soft tissues and overnight fixation in 4%
paraformaldehyde right femur were analyzed using a Skyscan
1172 instrument (Skyscan, Antwerp, Belgium) equipped with a
1.3Mp camera was used to capture 2D serial cross-sections, which
were used to reconstruct 3-dimensional images for the quantifi-
cation of the volume of bone in both the diaphysis and distal
metaphysis. Analyses of the bone microarchitecture were carried
out in a region of interest (ROI), which was defined as the
cancellous bone compartment beginning 0.6 mm proximal to the
most proximal point of the growth plate and extending proximally
1.0 mm, corresponding to approximately 1.55 mm thick region of
the distal femora. Nomenclature and abbreviations of micro-CT
parameters follow the recommendations of the American Society
of Bone and Mineral Research [34].
Histology and Histomorphometry
For histomorphometric and histology analyses the left femur
and tibia were fixed overnight in 4% paraformaldehyde, rinsed in
3 changes of PBS and embedded in polymethylmethacrylate
(MMA) or a mixture of 50% MMA and 50% glycolmethacrylate
(GMA). Serial 4- to 6-mm sections of MMA-embedded tissues
were left unstained or stained with von Kossa, while 4-mm MMA-
GMA decalcified sections were stained for alkaline phosphatase
(ALP) (osteoblasts), toluidine blue (osteocytes), and tartrate
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described previously [24]. Images were captured at two different
magnifications (406 and 1006) using a Nikon Eclipse E100
microscope (Nikon Instruments Inc., Melville, NY, USA) and the
primary histomorphometric data obtained using Bioquant Nova
Prime image analysis software (Bioquant Image Analysis Corp,
Nashville, Tennessee). Nomenclature and abbreviations conform
to those recommended by the American Society for Bone and
Mineral Research [35]. Histodynamic parameters MS/BS, MAR
and BFR/BS were measured on the same specimens as above,
using six representative fields per bone sample, in epifluorescent
light.
Serum Biochemistry and Bone Biomarkers
Serum concentrations of bone biomarkers and calciotropic
hormones were analyzed at the Ageing Bone Research Centre-
Nepean using commercial assays for serum C-Tx (ImmunoDiag-
nostic Systems Ltd, UK), P1NP (ImmunoDiagnostic Systems Ltd,
UK), PTH (Immunotopics Inc San Clemente, CA, USA) and
25(OH)D (ImmunoDiagnostic Systems Ltd, UK).
Ex-vivo cultures of bone marrow cells
To establish adherent bone marrow cultures, bone marrow
cells were obtained and induced to differentiate into osteoblast as
previously described [36]. Briefly, tibiae from four week-old
Lmna
2/2 and
+/2 and their WT controls (n=10 per group) were
flushed using a 21-gauge needle attached to a 10 ml syringe filled
with Dulbecco’s modified Eagle’s Medium (DMEM) (GIBCO
BRL, Gaithersburg, MD, USA). Cells were filtered through a cell
strainer with 70-micron nylon mesh (BD Bioscience, Bedford,
MA, USA) and then combined to produce a volume of 2 ml
containing ,10
7 cells/ml. Six-well plate cultures were then
established in triplicate, with each well containing a 100-ml
aliquot of cell suspension combined with 4 ml of fresh -MEM
medium. The cells were incubated in MSC growth media at
37uC with 5% humidified CO2 and isolated by their adherence to
tissue culture plastic. Medium was aspirated and replaced with
fresh medium to remove non-adherent cells every 2 to 3 days.
The adherent MSC were grown to ,80% confluence for about 7
days defined as MSC at passage 0, harvested with 0.25% trypsin
and 1 mM EDTA for 5 min at 37uC, diluted 1:3 in MSC growth
media, plated and grown to confluence for further expansion.
After 2
nd and 3
rd passages, MSC were used for subsequent
experiments.
To induce differentiation, a total of 10
4 cells were diluted in
osteogenic medium (prepared with DMEM, 10% FCS, 0.2 mM
dexamethasone, 10 mmol/L b glycerol phosphate and 50 mg/mL
ascorbic acid) and plated in six well plates. Media was aspirated
and replaced with fresh osteogenic medium every 3 days. After 21
days in culture, cells were washed with PBS, ethanol fixed, stained
for alkaline phosphatase, and counterstained with hematoxylin
(Sigma). The colonies with more than 10% of cells staining positive
for ALP were considered as colony forming units-osteoblasts
(CFU-OB). Two independent observers quantified the number of
CFU-OB using Nikon Eclipse E100 microscope (Nikon Instru-
ments Inc., Melville, NY, USA).
Semi-quantitative real time-polymerase chain reaction
(RT-PCR)
Bone marrow cells were flushed and isolated as previously
described. Total RNA was extracted from marrow cells using a
QIAGEN RNeasy Mini extraction kit following manufacturer’s
instructions (QIAGEN Pty, Doncaster, VIC, Australia; cat#
74104). First strand complementary DNA (cDNA) synthesis was
performed using 200 ng of total RNA, 50 ng random hexamers
and 50 units reverse transcriptase at 42uC for 1 hour, as described
by manufacturer (Bioline Australia Pty, Alexandria, NSW,
Australia; cat# BIO-65025). Real-time PCR for expressed genes
as markers for osteogenesis and Lamin A/C was performed in
duplicate in a total reaction volume of 25 ml, 10% of which was
cDNA (or water for non-template control), 3 mM MgCl2 and
250 nM of each forward and reverse specific primer for target
genes and normalizer. Primers for specific detection of mRNA
expression included: Lmna (F: 59-tgagtacaacctgcgctcac-39;R :5 9-
tgactaggttgtccccgaag-39); runt-related transcriptional factor 2
(RUNX2) (F: 59-gccgggaatgatgagaacta-39,R :5 9-ggaccgtccactgt-
cacttt-39); OPN (F: 59-tgcacccagatcctatagcc-39,R :5 9-ctccatcgtcat-
catcatcg-39); OCN (F: 59-cttggtgcacacctagcaga-39;5 9-ac-
cttattgccctcctgctt-39). All PCRs were performed in a Corbett
Rotor-Gene
TM 3000 (QIAGEN Pty) using SYBR green with no-
ROX reaction mix and a standard thermal profile as described by
supplier (Bioline Australia Pty, Alexandria, NSW, Australia; cat#
QT6750-02). Quantitative RT-PCR data was defined by thresh-
old cycle (Ct) normalized for the housekeeping gene glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) (F: 59-aactttggcattgtg-
gaagg-39,R :5 9-acacattgggggtaggaaca-39).
Western blot analysis
For western blot analysis, 20 mg of total protein were loaded on
polyacrylamide gels and separated by standard SDS-polyacryl-
amide gel electrophoresis. To control for differences in gel
migration, exposure time, antibody incubation etc, samples were
run on the same gels and transferred to the same PVDF
membranes (Amersham, UK). Blots were blocked overnight in
2.5% non-fat dried milk and probed with antibodies directed
against Lamin A/C, Runx2, OPN, MAN-1, and OCN (1:1000,
Santa Cruz Biotechnology, Santa Cruz, CA, USA). Positive
controls were included in all experiments as provided by the
manufacturer (Santa Cruz Biotechnology, Santa Cruz, CA, USA,
USA), to confirm antibody specificity. Secondary antibodies
conjugated to horseradish peroxidase were from Sigma (1:5000).
Antigen-antibody complexes were detected by chemiluminescence
using a kit of reagents from ECL (Amersham, UK) and blots were
exposed to high-performance chemiluminescence film (Amer-
sham, UK). Films were scanned and the optical density of each
specific band analysed using the ImageMaster program and
expressed as OD/mm2/100 mg of total protein. The signals were
quantified by densitometry and normalized according to Tubulin
density.
Runx2 activity measurement
Active Runx2 binding to DNA was determined using the
ELISA-based Runx2 activation TransAM
TM kit (Active Motif,
Rixensart, Belgium) as previously described [7,24]. The Trans-
AM Runx2 Kit contains a 96-well plate on which an oligonucle-
otide containing a Runx2 consensus-binding site (59-AACCACA-
39) has been immobilized. The active form of Runx2 contained in
nuclear extract specifically binds to this oligonucleotide. The
primary antibody used in the Trans-AM Runx2 Kit recognizes an
accessible epitope on Runx2 protein upon DNA binding. Addition
of a secondary horseradish peroxidase (HRP)-conjugated antibody
provides a sensitive colorimetric readout easily quantified by
spectophotometry (450 nm). To quantify active Runx2 binding,
15–20 mg of nuclear extract was measured using the Trans-AM
Runx2 Kit according to the manufacturer’s instructions (Active
Motif, Carlsbad, CA, USA).
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To determine the intranuclear distribution of Runx2 and MAN-
1, bone marrow cells were flushed and plated in two-well slides
containing MSC growth media as previously described. After
passage 2, cells were fixed with 95% methanol for 15 min and
incubated with MAN-1 or Runx2 antibodies (1:500) followed by a
rhodamine- or fluorescein-conjugated secondary antibody, respec-
tively. DAPI was used for nuclear counterstaining. Sections were
mounted using Vectashield Hard Set mounting medium with 49,6-
diamidino-2-phenylindole (Burlingame, CA) and viewed using an
LSM 510 Zeiss confocal microscope (Carl Zeiss, Thornwood, NY)
at 406and 1006magnification.
Statistical Analysis
Results are expressed as means 6 SD and differences between
groups of mice were determined by the Student t test and the
Mann-Whitney test. A P value of #0.05 was considered
statistically significant.
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